We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$130B
AUM Growth
+$12.3B
Cap. Flow
+$1.54B
Cap. Flow %
1.18%
Top 10 Hldgs %
17.24%
Holding
8,628
New
1,223
Increased
3,315
Reduced
2,707
Closed
1,164

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$548M
2
MU icon
Micron Technology
MU
+$461M
3
C icon
Citigroup
C
+$334M
4
AVGO icon
Broadcom
AVGO
+$319M
5
ABBV icon
AbbVie
ABBV
+$267M

Sector Composition

Rank Sector Weight
1 Technology 7.23%
2 Financials 5.58%
3 Industrials 4.98%
4 Consumer Discretionary 4.95%
5 Healthcare 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCRX icon
6951
CALL
BioCryst Pharmaceuticals
BCRX
$2.45B
$72K ﹤0.01%
13,800
-8,800
-39% -$45.1K
BW icon
6952
Babcock & Wilcox
BW
$1.54B
$72K ﹤0.01%
2,162
+1,027
+90% +$63.1K
VNET
6953
VNET Group
VNET
$2.16B
$72K ﹤0.01%
+12,621
New +$62.7K
ACHN
6954
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
$72K ﹤0.01%
16,100
+5,900
+58% +$26.2K
LABD icon
6955
CALL
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$40.3M
$71K ﹤0.01%
8
-7
-47% -$84.4K
ITI
6956
DELISTED
Iteris, Inc.
ITI
$71K ﹤0.01%
+10,616
New +$66.6K
FORK
6957
DELISTED
Fuling Global Inc
FORK
$71K ﹤0.01%
+12,062
New +$44.2K
GCAP
6958
DELISTED
Gain Capital Holdings, Inc.
GCAP
$71K ﹤0.01%
+11,102
New +$72.3K
CVEO icon
6959
Civeo
CVEO
$345M
$70K ﹤0.01%
+2,042
New +$52.4K
UEC icon
6960
CALL
Uranium Energy
UEC
$5.55B
$70K ﹤0.01%
50,800
+23,200
+84% +$33.9K
XXII
6961
CALL
22nd Century Group
XXII
$1.5M
0
KND
6962
PUT
DELISTED
Kindred Healthcare
KND
$70K ﹤0.01%
10,300
-280,000
-96% -$2.38M
VVUS
6963
DELISTED
Vivus Inc
VVUS
$70K ﹤0.01%
7,118
-1,306
-16% -$13.8K
AHT
6964
CALL
Ashford Hospitality Trust
AHT
$20.6M
$69K ﹤0.01%
11
-3
-21% -$18.5K
XCO
6965
CALL
DELISTED
Exco Resources
XCO
$69K ﹤0.01%
+51,700
New +$87.2K
ALTO icon
6966
CALL
Alto Ingredients
ALTO
$325M
$68K ﹤0.01%
12,300
-2,700
-18% -$14.7K
DRRX
6967
DELISTED
DURECT Corp
DRRX
$68K ﹤0.01%
3,869
+852
+28% +$14.3K
MR
6968
PUT
DELISTED
Montage Resources Corporation Common Stock
MR
$67K ﹤0.01%
1,773
-1,700
-49% -$63.8K
ISEE
6969
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$66K ﹤0.01%
23,500
-1,900
-7% -$5.13K
GSV
6970
DELISTED
Gold Standard Ventures Corp.
GSV
$66K ﹤0.01%
40,755
-78,542
-66% -$135K
ATRS
6971
PUT
DELISTED
Antares Pharma, Inc.
ATRS
$66K ﹤0.01%
+20,500
New +$63.3K
ZN
6972
CALL
DELISTED
Zion Oil & Gas, Inc.
ZN
$66K ﹤0.01%
19,500
-9,100
-32% -$33.4K
QHC
6973
DELISTED
Quorum Health Corporation
QHC
$66K ﹤0.01%
12,750
-10,075
-44% -$41K
CASC
6974
DELISTED
Cascadian Therapeutics, Inc.
CASC
$66K ﹤0.01%
16,126
-3,361
-17% -$12.9K
FTK icon
6975
PUT
Flotek Industries
FTK
$1.3B
$63K ﹤0.01%
2,250
+300
+15% +$11.9K

Similar funds

Ken Griffin's Q3 2017 Portfolio in Review

As of Q3 2017, Ken Griffin held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Ken Griffin's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.

By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.4% a quarter earlier, followed by Financials and Industrials.

  • Ken Griffin's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
  • Ken Griffin added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
  • Ken Griffin's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
  • Ken Griffin fully exited Citigroup in Q3 2017, selling an estimated $334M.
  • Ken Griffin's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
  • Ken Griffin opened 1,223 new positions and closed 1,164 in Q3 2017.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $130B.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.